Dr. Aman M. Amanullah

An internationally recognized leader in structural heart disease, Dr. Généreux has been a practicing interventional cardiologist for more than 15 years. He is the director of the structural heart program at Morristown Medical Center, has served as the primary or co-investigator on more than 20 clinical trials, and has published more than 350 articles in peer-reviewed journals. He is currently the principal investigator of the EARLY TAVR trial and the PROGRESS trial, two major studies in the field of aortic valve disease. A celebrated clinical researcher since the beginning of his career, he was awarded the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group for the last four years. Dr. Généreux is also involved in multiple early-stage companies in the field of interventional cardiology and heart failure. He received his medical degree from the Université de Montréal, Montréal, Québec, Canada, his cardiology and interventional cardiology degrees from Université de Sherbrooke and Sacré-Coeur Hospital, Montreal, Canada, and performed his advanced interventional cardiology and structural heart fellowship at Columbia University and Cardiovascular Research Foundation, in New York city. Dr. Genereux is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Coronary Heart Disease, Aortic Valve Replacement, and Percutaneous Coronary Intervention (PCI).

"Philosophy of care | I perform very complex cardiac and aortic reconstructive procedures. My philosophy regarding my patients is to complete these operations with the utmost skill, perfection and result as possible. Just as importantly, I spend time with my patients and their families to explain in great detail their condition and how we are going to treat it. This includes all the potential options available. My primary goal is to allow my patients some choice but, more importantly, to make sure they completely understand their disease process. My focus for many years has been a ""disease management process"" that fosters a long-term commitment to my patients revolving around the specifics of aortic and valvular heart disease. | Why I entered medicine | Initially, I wanted to be a political scientist; however, a number of life experiences changed that. My grandfather had Lou Gehrig’s disease and lived with us when I was growing up. This daily experience had a profound effect during formative years in high school. Interestingly, our next-door neighbor was a general/vascular surgeon, and I came to know him quite well. He was my initial mentor in this field. I initially studied engineering but was fascinated with cardiac physiology and this translated into medicine and cardiac surgery specifically. However, the passion and commitment to treat patients and their suffering was first embedded in my psyche secondary to witnessing, in all domains, my grandfather's demise from Lou Gehrig’s disease. | Community involvement | President, The Thoracic Surgery Foundation, impacting the global community by delivering quality thoracic care to lower- and middle-income countries across the world. | Personal interests | I enjoy traveling the world, Philadelphia professional sports, golfing and coaching baseball.". Dr. Bavaria is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Bicuspid Aortic Valve, Thoracic Aortic Aneurysm, Aortic Dissection, Aortic Valve Replacement, and Heart Valve Repair.

Chunguang Chen is a Cardiologist in Newark,, New Jersey. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Infective Endocarditis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).